Clinical Leader
About
Professor David Adler
Professional context for the 2026 publication record.
Professor David Adler is Chief Scientific & Medical Officer of the PATHORA Institute of Pathology & Tissue Medicine. He is a senior pharmaceutical leader in oncology drug development and translational medicine with over 15 years of experience, including a decade in senior leadership at Bayer AG’s Global Oncology Clinical Development organization.
He holds academic appointments at the Hebrew University of Jerusalem, Ben-Gurion University of the Negev, and the University of Bonn. His work focuses on the strategic decisions that shape the path from scientific discovery through clinical development and influence whether promising innovations ultimately become medicines.
01 · Core Expertise
Oncology Clinical Drug Development & R&D Thought Leadership
Specialist life-science writing on oncology development strategy, evidence generation, translational research, R&D decision-making and clinical execution.
Life Science Leader
-
When Should R&D Organize Around The Therapy, Not Just The Drug?
Featured by PDA.
-
When Should R&D Turn Back?
Featured by PDA.
pharmaphorum
EACR Magazine / The Cancer Researcher
Clinical Lab Products
02 · High-Level Policy
Health, Pharmaceutical & Science Policy
Commentary connecting drug development, cancer research, supply resilience, biomedical investment and access to broader public-policy questions.
The Well News
- What Can the FDA Learn From a Regulator Being Built for Today’s Science?
- FDA Moves to Broaden Cancer Trial Access. Every Exclusion Should Have to Earn Its Place
- As FDA Sets AI Principles for Drug Development, How Much Evidence Is Enough?
- A Melanoma Drug Went From Two Rejections to Approval. The FDA's Reason Should Be Easier to Find.
LSE Impact of Social Sciences
Washington Examiner
- America Didn't Decline in Cancer Research. China Just Caught Up
- A Chemo Shortage Is Headed for America. India Just Showed Us Why
- Trump's Beijing Blind Spots: The Two Glaring Holes in His War on High Drug Prices
- Trump Wants to Cut NIH. What Future Medicines Will Your Family Lose?
- Right Goal, Wrong Strategy: Why Trump's 'Made in America' Plan Leaves Us Vulnerable
DC Journal / InsideSources
Daily Montanan
03 · Business & Decision-Making
Business & Decision-Making
Writing that extends evidence-based decision principles beyond biomedicine into organizational strategy and leadership.
The CEO Magazine
The European Business Review
04 · Coverage & Journal Features
Independent Media Coverage & Journal Features
Independent reporting and profiles about Professor Adler, alongside selected journal features.
International Journal of Oncology Journal cover feature
-
Professor David Adler — Cover Feature & Profile
Featured on the cover of Volume 69, Issue 5 (November 2026), accompanied by a two-page cover profile highlighting his career in oncology drug development, translational medicine, academic work and the advancement of scientific discoveries toward clinical development. View the November 2026 issue.
The Scientist Media coverage
Ynet News Media coverage
-
From Biomedical Discovery to Medicines: How Israel Can Turn Research Into Biotech Success
Spanish translation published by the Consulate General of Israel in Guayaquil; also republished by Herencia Genética y Enfermedad.
BioRegio STERN Media coverage
05 · Innovation Ecosystems
Biotechnology, Translational Medicine & Innovation
Writing on biomedical innovation, biotechnology ecosystems, research translation, capability building and regional life-science strategy.
Jewish Journal
JNS
Globes
06 · Public Commentary
Oncology, Drug Development & Capability Strategy
Accessible public commentary using strategic analogies to explore cancer, drug-development decisions, biomedical innovation and national capability.
The Times of Israel
- A Mossad Operation Against Cancer
- Pegasus and the Next Way In
- Unit 8200: What Comes After the Signal?
- When the Iron Dome Chooses Not to Engage
- Krav Maga: The Move We Did Not Plan For
- Israel's Brain Drain: Time for a Scan and a Neurological Exam?
- Operation Precision Aliyah
- Taftefet (טפטפת): Where Should Israel's Next Drop Go?
07 · News
News & Announcements
Corporate announcements are separated from independent media coverage to keep the distinction clear.
BioSpace Announcement
08 · Authored Works
Books
Medicine, Fiction & Interactive
Ella and the Medicine Mystery
- How a Cancer Clue Can Become a Medicine
- How a Cancer Cell Hides from the Immune System
- How Does a Cancer Cell Travel Through the Body
- How Do Doctors Find Out What Kind of Cancer It Is
- Why Do Cancer Cells Keep Growing
- Why Do the Checkups Continue After Cancer Treatment
- Why Do Doctors Use More Than One Cancer Treatment